Sandoz receives positive CHMP opinion for citrate-free high
Sandoz is seeking approval of high concentration formulation (HCF) adalimumab for use in all indications of reference
Globe Newswire30-01-2023, 13:17
FSIS Recall Release 003-2023 - Conagra Brands - Processing 1-02-2023, 12:00